Tianfeng Securities released a research report on April 26 stating that it gave Pumen Technology (688389.SH) a buying rating. The main reasons for the rating include: 1) growth in all business segments, and growth in domestic and overseas markets; 2) building new brands and deepening internationalization; 3) striving for excellence in the field of in vitro diagnosis, and repeated introduction of new products in the field of treatment and rehabilitation. (Mainichi Keizai Shimbun)
天风证券4月26日发布研报称，给予普门科技（688389.SH）买入评级。评级理由主要包括：1）各业务板块均有增长，海内外市场均实现增长；2）塑造新品牌，深耕国际化；3）体外诊断领域精益求精，治疗与康复领域新品迭出。（每日经济新闻）
Tianfeng Securities released a research report on April 26 stating that it gave Pumen Technology (688389.SH) a buying rating. The main reasons for the rating include: 1) growth in all business segments, and growth in domestic and overseas markets; 2) buil
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.